Efficacy and safety of propofol sedation during therapeutic endoscopy

Efficacy and safety of propofol sedation during therapeutic endoscopy - propofol sedation during therapeutic endoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010707

Enrollment

100

Registered

2013-05-13

Start date

2013-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early gastric cancer, pancreato-biliary disease, esophago-gastric varices

Interventions

propofol sedation therapeutic endoscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1,Patients will receive therapeutic endoscopy (ESD, ERCP, EIS). 2, ECOG-Performanece: 0 or 1 3, over 20 years old 4, nomal liver and renal function

Exclusion criteria

Exclusion criteria: 1, liver and renal dysfunction 2, Patients disagree with propofol sedatoon

Design outcomes

Primary

Measure	Time frame
treatment outocome	—

Secondary

Measure	Time frame
complication	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026